Developer of molecular point-of-care diagnostic assays designed to diagnose infectious diseases and cancer. The company's assays use isothermal amplification technology for patient-oriented diagnostics and are also suited to quickly clarify issues related to tumour diagnostics, enabling doctors to make a diagnosis after 30 minutes and coordinate the treatment.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Out of Business | 01-Jan-2019 | Completed | Out of Business | |||
2. Early Stage VC (Series A) | 24-Apr-2017 | Completed | Startup | |||
1. Grant | $167K | Completed | Startup |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Stefan Kulick | Co-Founder & Managing Director | ||
Guido Krupp | Co-Founder | ||
Peter Scheinert | Co-Founder |